The use of interferon alpha-2A, a biological modifier with anti-angiogenetic effects, in the treatment of small cell lung cancer : a clinical study

about
author
inLanguage
  • en
isPartOf
name
  • The use of interferon alpha-2A, a biological modifier with anti-angiogenetic effects, in the treatment of small cell lung cancer : a clinical study
P60049

Instances

The use of interferon alpha-2A, a biological modifier with anti-angiogenetic effects, in the treatment of small cell lung cancer : a clinical study

datePublished
  • 2000
description
  • 6 excerpts.
  • kuvitettu
  • Tiivistelmä ja 6 erip. - Nimiösivulla myös: Department of Medicine, Division of Pulmonary and Internal Medicine, Helsinki University Central Hospital
identifier
  • propertyID: FI-FENNI value: 668128
  • propertyID: FI-MELINDA value: 003319294
  • propertyID: skl value: fx668128
isbn
  • 9529127650
isPartOf
name
  • The use of interferon alpha-2A, a biological modifier with anti-angiogenetic effects, in the treatment of small cell lung cancer : a clinical study
numberOfPages
  • 104, [56] s.
P60048
P60050
publication
  • location: Helsinki organizer: T. Savolainen
publisher
  • T. Savolainen

Download this resource as RDF: